METHYLPHENIDATE HYDROCHLORIDE | N212038 | KNOA PHARMA LLC
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 9974752 | Oct 30, 2035 | — | — | Yes | — | — |
| 10111839 | Oct 30, 2035 | — | — | — | — | |
| 10292938 | Oct 30, 2035 | — | — | Yes | — | — |
| 10292939 | Oct 30, 2035 | — | — | Yes | — | |
| 10449159 | Oct 30, 2035 | — | — | — | — | |
| 10500162 | Oct 30, 2035 | — | — | — | — | |
| 10507186 | Oct 30, 2035 | — | — | Yes | — | — |
| 10512612 | Oct 30, 2035 | — | — | Yes | — | — |
| 10512613 | Oct 30, 2035 | — | — | — | — | |
| 10568841 | Oct 30, 2035 | — | — | Yes | — | |
| 10688060 | Oct 30, 2035 | — | — | Yes | — | — |
| 10722473 | Nov 19, 2038 | — | — | — | — |
KNOA PHARMA LLC acquired ownership of the Adhansia XR (methylphenidate hydrochloride) NDA 212038 from Purdue Pharma LP, as reflected in the applicant transfer in the FDA database.
Old: PURDUE PHARMA LP
New: KNOA PHARMA LLC
KNOA Pharma acquired NDA 212038 for ADHANSIA XR (methylphenidate hydrochloride) from Purdue Pharma LP.
Old: PURDUE PHARMA LP
New: KNOA PHARMA
KNOA PHARMA LLC acquired rights to ADHANSIA XR (methylphenidate hydrochloride) NDA 212038, replacing PURDUE PHARMA LP as the listed applicant.
Old: PURDUE PHARMA LP
New: KNOA PHARMA LLC
KNOA PHARMA LLC replaced PURDUE PHARMA LP as the applicant for ADHANSIA XR (methylphenidate hydrochloride) NDA 212038.
Old: PURDUE PHARMA LP
New: KNOA PHARMA LLC
Applicant for Adhansia XR (methylphenidate hydrochloride) NDA 212038 changed from Purdue Pharma LP to Knoa Pharma.
Old: PURDUE PHARMA LP
New: KNOA PHARMA
KNOA PHARMA LLC acquired ownership of ADHANSIA XR (methylphenidate hydrochloride) NDA 212038 from Purdue Pharma LP, effective through the applicant change recorded in the FDA database.
Old: PURDUE PHARMA LP
New: KNOA PHARMA LLC
KNOA PHARMA LLC became the listed applicant for Adhansia XR (methylphenidate hydrochloride) NDA 212038, replacing Purdue Pharma LP.
Old: PURDUE PHARMA LP
New: KNOA PHARMA LLC
KNOA PHARMA acquired ownership of ADHANSIA XR (methylphenidate hydrochloride) NDA 212038 from Purdue Pharma LP.
Old: PURDUE PHARMA LP
New: KNOA PHARMA
KNOA PHARMA replaced Purdue Pharma LP as the applicant for methylphenidate hydrochloride extended-release capsules (ADHANSIA XR, NDA 212038).
Old: PURDUE PHARMA LP
New: KNOA PHARMA
KNOA Pharma acquired rights to Adhansia XR (methylphenidate hydrochloride) NDA 212038, replacing Purdue Pharma LP as the applicant of record.
Old: PURDUE PHARMA LP
New: KNOA PHARMA
Purdue Pharma LP transferred NDA 212038 for Adhansia XR (methylphenidate hydrochloride) to KNOA Pharma.
Old: PURDUE PHARMA LP
New: KNOA PHARMA
KNOA PHARMA LLC became the applicant of record for Adhansia XR (methylphenidate hydrochloride) NDA 212038, replacing Purdue Pharma LP.
Old: PURDUE PHARMA LP
New: KNOA PHARMA LLC